GL1X · GenesisL1 explorer

Research workbench

Crystal structure of thrombin in complex with a novel glucose- conjugated potent inhibitor

Analyse Crystal structure of thrombin in complex with a novel glucose- conjugated… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6EO9
Type
protein
Length
284 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
UniProt
P00734, P09945
Ligands
2OJ

Structure

x-ray diffraction · 3 distinct chains.

ChainMoleculeTypeResiduesSecondary structureUniProt
H—protein250—P00734
L—protein26—P00734
I—protein8—P09945

Ligands and binding sites

  • 2OJ · N-(2-{[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methoxy}-6-{3-[(2,3,4,6-tetra-O-acetyl-beta-D-glucopyranosyl)oxy]propoxy}phenyl)-1-(propan-2-yl) piperidine-4-carboxamide · ligand · chains H
  • DMS · Dimethyl sulfoxide · additive · 6 copies · chains H, L

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 6EO9 · Crystal structure of thrombin in complex with a novel glucose-conjugated potent inhibitor · the same entry in another collection · chain H against H, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.